Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Type of Blood Stem Cell Could Help Solve Platelet Shortage

Published: Tuesday, August 13, 2013
Last Updated: Tuesday, August 13, 2013
Bookmark and Share
Scientists have identified a new type of bone marrow stem cell in mice that is primed to produce large numbers of vital blood-clotting platelets.

The breakthrough may eventually lead to the development of new treatments to restore platelets in patients who have undergone chemotherapy or a bone marrow transplant. The research, published in Nature, was led by the MRC Weatherall Institute of Molecular Medicine (WIMM), at the University of Oxford.

Blood cells are made by a small pool of stem cells in the bone marrow, which replenish the blood at a rate of millions of cells per second. These cells can self-renew (copy themselves) and give rise to all the different cell types that make up the blood system, including white and red blood cells, and platelets.

Platelets help the blood to clot by clumping together at the site of bleeding. Having too few platelets can result in excessive bleeding and is a common side effect in cancer patients, whose natural reservoir of platelets has been destroyed by the disease or by treatment. This can be life-threatening in the weeks immediately following chemotherapy or a bone marrow transplant as it takes time for blood stem cells to replenish platelets to safe levels.

Many patients who undergo these treatments are given platelet transfusions to protect them from bleeding. But donated platelets can only be stored for a few days and demand often outstrips supply. Researchers have therefore been looking for a way to rapidly and durably increase the production of platelets to reduce the risk of bleeding.

Scientists had thought there was just one type of blood stem cell. This study, led by Professors Sten Eirik W Jacobsen and Claus Nerlov, has revealed a previously undiscovered subset of platelet-primed blood stem cells that can self-renew and produce some other cell types that make up the blood, but are particularly geared towards platelet production.

The researchers also found that different subtypes of blood stem cell are organised into a hierarchy, with platelet-primed cells at the top. These platelet-primed cells are able to also replenish other stem cell types that mostly generate the vital blood cells of the immune system.

Transplanting just one platelet-primed stem cell into mice that lacked their own bone marrow was enough to stably restore more than 10 per cent of their platelets, suggesting that these cells can generate a huge number of platelets in a sustainable manner. Future studies by the group will focus on whether or not this can be achieved quickly enough to benefit patients in a clinical transplantation setting.

Professor Sten Eirik Jacobsen from the MRC Molecular Haematology Unit and the Haematopoietic Stem Cell Biology Unit, part of the MRC WIMM at the University of Oxford, said:

“We used to think that there was just one type of blood stem cell that could self-renew and give rise to all the different cell types in the blood. But here we’ve identified a new type of stem cell that is very driven, at a molecular and functional level, towards making platelets.
 
“Now that we know these cells exist, we can start thinking about devising new strategies to enhance platelet output – either by generating and transplanting more of this type of cell into a recipient, or by somehow stimulating their own pool of stem cells to restore platelet levels more quickly. But first we need to see whether we can find the same cells in human tissue and understand more about how they are regulated.”

Professor Alastair Poole, a platelet biologist and member of the MRC’s Molecular and Cellular Medicine Board, which funded the research, said:

“Blood stem cells were the first ever stem cells to be identified by scientists, but there is still a lot we don’t fully understand about how these cells are controlled in the body. The discovery of a distinct class of blood stem cells within the bone marrow adds a great deal to our understanding and sheds light on how platelet generation in the body is regulated.
 
“Since platelets are key to blood clotting and loss of platelets can lead to potentially life-threatening bleeding disorders, this discovery of a potent platelet-generating stem cell in the bone marrow has exciting potential. It will be important to identify these stem cells in human tissue, because if replicated in humans they may hold the key to new treatments that will benefit patients with cancer and other serious platelet disorders.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Liver Regrown from Stem Cells
Scientists have repaired a damaged liver in a mouse by transplanting stem cells grown in the laboratory.
Wednesday, July 22, 2015
MRC, GSK and Five Leading UK Universities Collaborate
Collaboration to crack difficult disease areas.
Thursday, July 16, 2015
‘Mini Bile Ducts’ used to Discover New Drugs that could Prevent Liver Damage
An experimental cystic fibrosis drug has been shown to prevent the disease’s damage to the liver, thanks to a world-first where scientists grew mini bile ducts in the lab.
Tuesday, July 14, 2015
First RNAi Meiosis Screen Reveals Genes Essential to Generate Eggs
Screening techniques developed leading to the discovery of genes essential for meiosis in mammals.
Wednesday, July 08, 2015
Study Identifies New Way to Kill the Malaria Parasite
Scientists have discovered new ways in which the malaria parasite survives in the blood stream of its victims, a discovery that could pave the way to new treatments for the disease.
Tuesday, July 07, 2015
Making Vaccines More Effective In The Elderly
Compound shown to restore the immune system’s inbuilt memory.
Tuesday, November 11, 2014
Immune Organ Regenerated in Mice
Scientists have for the first time used regenerative medicine to fully restore a degenerated organ in a living animal.
Tuesday, April 08, 2014
AstraZeneca, MRC Collaboration to Create New Centre for Early Drug Discovery
The Companies today announced the groundbreaking collaboration aimed at better understanding the mechanisms of human disease. The collaboration will see the creation of a joint research facility at AstraZeneca’s new R&D centre in Cambridge in the UK.
Monday, March 31, 2014
MRC Invests £32M to Improve Data Research
Investment will improve capability, capacity and capital infrastructure in medical bioinformatics.
Friday, February 07, 2014
Redirecting the Rules of Attraction in Fruit Flies
MRC researchers have discovered a biological switch that determines which part of the fruit fly’s brain responds to pheromones, depending on whether the fruit fly is male or female.
Friday, December 20, 2013
A Gene Mutation for Excessive Alcohol Drinking Found
UK researchers have discovered a gene that regulates alcohol consumption and when faulty can cause excessive drinking.
Wednesday, November 27, 2013
MRC Laboratory of Molecular Biology Alumni Awarded Nobel Prize for Chemistry
Professor Michael Levitt, Professor Arieh Warshel and Professor Martin Karplus awarded the 2013 Nobel Prize in Chemistry.
Monday, October 14, 2013
Study Leads to Alzheimer's Breakthrough
Researchers at the Medical Research Council Toxicology Unit have used an orally-administered compound to block a major pathway leading to brain cell death in mice, preventing neurodegeneration.
Thursday, October 10, 2013
£25m to Kick-Start ‘Industrial Revolution’ in Regenerative Medicine
Applications will include Parkinson’s disease, cardiovascular disease, wound and musculoskeletal repair, eye disorders and deafness.
Wednesday, September 11, 2013
3D Tissue Grown from Stem Cells - New Model System for Brain Development
An international team of researchers has used stem cells to create a 3D structure that mimics early human brain development.
Monday, September 02, 2013
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!